Canary Capital Launches the First U.S. Spot Staked INJ ETF (Ticker: INJC)

Brentwood, Tennessee, USA, November 6th, 2026, FinanceWire

Canary Capital Group LLC (“Canary Capital”), a digital asset investment management firm, today announced the launch of the Canary Staked INJ ETF (Ticker: INJC), listed on Nasdaq. The Fund seeks to provide exposure to the price of INJ, the native token of the Injective blockchain network. In addition, the Fund also seeks to earn additional INJ through participation in the Injective network’s proof-of-stake validation process, with net staking rewards reflected in the Fund’s net asset value. 

“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards,” said Steven McClurg, CEO of Canary Capital. “Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure.” 

Injective is a Layer-1 blockchain designed to serve as the technological foundation for on-chain finance. Its purpose-built architecture offers developers pre-built, plug-and-play financial modules, including a fully onchain order book exchange module, enabling rapid development of tokenization, trading, derivatives, and other financial applications. INJ is used to secure the network through staking, to participate in governance, and to pay transaction and trading fees. 

The network also features a unique Community Buyback mechanism that regularly removes INJ from circulation using a portion of revenue generated by applications on the network. Injective has tokenized over $1 Billion in assets to date*, ranking it among the top blockchains for Real-World Assets (RWAs). As of October 22nd, 2026, Injective had processed more than 3.13 billion transactions and permanently burned more than 7.27 million INJ (~$58 million USD) across its monthly token buybacks. In addition, the analytics platform Token Terminal reports approximately 257,300* monthly active addresses on Injective. 

Recent upgrades include Injective Mint, which enables institutions to issue and manage tokenized assets with controls over ownership and transfers. Injective also showcased CypherOS which provides a full stack privacy platform capable of enabling confidential trading, transactions and tokenization. Also, over $25 million* of the native USDC stablecoin has been issued on Injective to support payments and settlement across the network. 

“Investors can now gain exposure to INJ through the brokerage accounts they already use,” said Eric Chen, Co-Founder of Injective Foundation. “We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors, giving them a familiar way to access the asset that powers Injective.” 

For more information on INJC, click here.

Media Contacts 

Canary Capital 

media@canaryetfs.com 

About Canary Capital 

Canary Capital is an investment management firm that blends rigorous risk management, strategic foresight, and innovative thinking to deliver private placement strategies, crypto hedge fund solutions, treasury management solutions, and publicly traded funds, with a focus on enterprise technology. 

About Injective: 

Injective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like EVM (Ethereum Virtual Machine) and WASM (WebAssembly), connect to native financial modules, and launch markets with deep liquidity from day one. INJ is the native token powering the rapidly growing Injective ecosystem and the new internet economy. 

*As of October 2026 

USDC – USDC is a stable digital dollar enabling fast, cheap, global blockchain transactions. 

The Canary Staked INJ ETF (Ticker: INJC) is an exchange-traded product that is not registered under the Investment Company Act of 1940 (the “1940 Act”) and therefore is not subject to the same regulations and protections as ETFs and mutual funds registered under the 1940 Act. Investing involves risk, including the possible loss of principal. An investment in INJC is subject to a high degree of risk and heightened volatility and is not suitable for investors who cannot afford the loss of their entire investment.

The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at https://canaryetfs.com/INJC/prospectus/. Read it carefully before investing. 

An investment in INJC is not a direct investment in INJ. Staking rewards are not indicative of the Fund’s performance, are not guaranteed, and may change frequently, including experiencing significant declines. Digital assets, such as INJ, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments. 

INJC is subject to rapid price swings, including as a result of actions and statements by influencers and the media, change of assets, and other factors. There is no assurance that INJC will maintain its value over the long-term. 

Staking provides the Trust with the opportunity to create and earn additional INJ. The Trust will be entitled to all INJ generated by the Trust’s staking, after deduction of certain staking-related expenses. This additional INJ will increase the net assets of the Trust, benefiting Shareholders. 

Certain of such INJ may be treated as income to the Trust and may be held for future distribution to Shareholders, subject to procedures and requirements disclosed elsewhere in the Prospectus. 

Staking comes with a risk of loss of INJ. None of the Fund’s assets, including any staked assets, are subject to the protections enjoyed by depositors with Federal Deposit Insurance Corporation (“FDIC”) or Securities Investor Protection Corporation (SIPC) member institutions. The staked assets may also be subject to “slashing” penalties. Slashings occur when a validator attests to two different histories of the chain and penalties occur when a validator is offline for a prolonged period of time. The Fund itself will not engage in staking activities, including the operation of a validator node. Instead, the staking program will be administered by the Fund’s sponsor, who will utilize service providers including the custodians and staking providers. While the Fund’s sponsor does not expect the activities of the staking providers to result in slashing penalties, there can be no guarantee that slashing penalties will not occur. Furthermore, the custodians’ and staking providers’ liability to the Fund for the actions associated with the Staking Program is limited, and the custodians and staking providers may lack the assets or insurance in order to support the recovery of any losses incurred. Accordingly, there can be no guarantee that the Fund would recover any of its staked assets, or the value thereof, if it is subject to slashing or penalties. 

The Fund is new with a limited operating history. 

Paralel Distributors LLC, Marketing Agent. Paralel is unaffiliated with Canary Capital.

Contact

Sarah Cohen
sarah@sjc-pr.com

Cyprus IVF Centre Explains Why Similarly Graded Embryos May Develop Differently

Nicosia, Cyprus, 6th Nov 2026 – Cyprus IVF Centre has shared patient information explaining why two embryos that receive the same grade do not necessarily have the same potential.

Embryo grading is based on visible characteristics, including cell development and morphology. It provides valuable information about embryo quality during IVF treatment.

Embryo grading assesses an embryo’s appearance and development; it does not determine its chromosomal status. Genetic testing, where clinically indicated, evaluates a different aspect of the embryo and likewise cannot guarantee implantation or treatment success.

However, grading cannot fully predict an embryo’s developmental potential or implantation outcome. Even embryos with the same grade may behave differently, as factors beyond their appearance can influence development.

At Cyprus IVF Centre, the embryology team considers embryo grading alongside other relevant developmental and clinical information when assessing embryos for treatment.

Embryo grading supports the assessment of embryos. It does not guarantee implantation or treatment success.

“Two embryos can receive the same grade and still develop differently. Grading gives our embryology team valuable information, which we consider alongside other developmental and clinical information when assessing embryos. Embryo grading is an important part of the picture, but never the whole picture.”

— Ümit İnak, Director, Cyprus IVF Centre

Patients considering treatment are welcome to ask the team how their embryos will be assessed and what grading means for their own treatment. More information is available at:

embryo grading in IVF

Medically reviewed by the Cyprus IVF Centre Medical and Embryology Team, 5 November 2026

About Cyprus IVF Centre

Cyprus IVF Centre, home of Team Miracle, is an IVF and fertility clinic in Cyprus providing assisted reproductive treatment for UK and international patients. Fertility care is supported by clinical and embryology teams, with laboratory processes forming an integral part of its treatment services.

Media Contact

Organization: Team Miracle – Cyprus IVF Centre

Contact Person: Team Miracle – Cyprus IVF Centre

Website: https://cyprusivfcentre.com/

Email: Send Email

City: Nicosia

Country: Cyprus

Release id: 50535

View source version on King Newswire:
Cyprus IVF Centre Explains Why Similarly Graded Embryos May Develop Differently

file

FX Junction Publishes Marketplace Review Showing Copy Traders Favor Longer Verified Track Records Over Higher Returns

Fomboni, Comoros, November 6th, 2026, FinanceWire

FX Junction has published findings from a review of copy-trading activity on its marketplace, revealing that investors tend to follow traders with longer verified trading histories rather than those with the highest returns. The review highlights the importance of established trading records in investor decisions and provides insight into copy-trading behavior across the platform.

In copy trading, also called social trading, an investor links their own brokerage account to the account of another trader, known as a signal provider. From that point, every position the chosen trader opens is mirrored automatically in the investor’s account, scaled to the amount the investor has allocated. The investor’s money never leaves their own broker; what is shared is the trading decision, not the capital.

Across the platform’s verified signal providers, the distribution of copying activity is the point. Fewer than six in ten of them have attracted copiers; the rest have none.

Among those who are copied, the allocation runs against the return table. The five best-performing accounts on the platform, with total returns between 197 and 273 percent, together account for less than half a percent of all copying links. Their verified track records run from under seven months to just over fifteen. Accounts ranked below them returning 192 and 182 percent hold more than a quarter of all copying links on the platform and their verified histories are more than three times longer than the longest record among the top five.

Measured Across The Whole Marketplace, The Pattern Holds:

Length of record: providers with at least one copier have a median verified history of 21.6 months. Providers with no copiers have a median of 8.8 months.

Returns: the median total return is 25.2 percent for copied providers and 26.8 percent for providers with no copiers – effectively the same.

Own capital at stake: the median account equity of a copied provider is 25,237 US dollars, against 3,741 US dollars for providers with no copiers.

The platform’s wider counters stood at 41,008 registered members, 26,261,890 trades executed and 12,681 linked trading accounts as of 4 November 2026. Member funds always remain with the trader’s own broker. FX Junction does not hold client capital.

About FX Junction

The investment and trading platform FX Junction is one of the world’s leading social trading networks. In the area of CFDs and forex, FX Junction had already established itself as one of the global leaders among social platforms for traders.

FX Junction was founded in 2011. The company’s launch was backed by a Swiss investor through Pine Group SA, and its U.S. expansion led by Ryan Novak.

For more information about the company, visit: https://www.fxjunction.com

Risk Warning

FX Junction does not provide investment advice and individual traders should make their own decisions or seek independent advice. The value of investment can go down as well as up and may receive back less than the original investment. 

Trading in Leverage products carries a high level of risk and may not be suitable for all investors. Past performance of an investment is no guide to its performance in the future. Investments, or income from them, can go down as well as up. May not necessarily get back the amount that invested. All opinions, news, analysis, prices or other information contained in the communication and on the website, are provided as general market commentary and do not constitute investment advice, nor a solicitation or recommendation to buy or sell any financial instruments or other financial products or services.

Contact

Team of analysts
FX Junction
Marketing@fxjunction.com

ValueX (VLX) Announces Dual Listing on Gate.io and MEXC, Expanding Its Global Web3 Carbon Economy Ecosystem

ValueX (VLX) is scheduled to list on two major global cryptocurrency exchanges on November 7, 2026, at 08:00 UTC.

Panama City, Panama, 6th Nov 2026 — VLX Aetherflow Technologies INC has announced the planned simultaneous listing of its digital asset, ValueX (VLX), on global cryptocurrency exchanges Gate.io and MEXC.

The upcoming listings mark a key milestone in ValueX’s global expansion strategy and its mission to connect blockchain technology with real-world environmental industries.

Advancing the Web3 Carbon Economy

ValueX is developing a blockchain-based carbon economy ecosystem utilizing Avalanche-based, EVM-compatible technology. The project aims to enhance transparency, traceability, and reliability in carbon-related data through blockchain-integrated Measurement, Reporting, and Verification (MRV) systems. Its primary application areas include maritime transportation, forestry, and renewable energy.

Building a Global Blockchain Ecosystem

Through its ValueX Chain infrastructure, the project seeks to integrate environmental data, IoT technologies, and decentralized finance (DeFi) into a scalable Web3 ecosystem. The planned Gate.io and MEXC listings are expected to increase global accessibility and support broader participation from blockchain developers, environmental businesses, and digital asset communities.

ValueX aims to accelerate the digital transformation of the carbon economy by connecting environmental sustainability with blockchain innovation.

Listing Information

  • Token: ValueX (VLX)
  • Exchanges: Gate.io & MEXC
  • Listing Date: November 7, 2026
  • Listing Time: 08:00 UTC
  • Issuer: VLX Aetherflow Technologies INC

Listing details are subject to official exchange confirmation. This announcement does not constitute investment advice.

Media Contact

Organization: VLX Aetherflow Technologies INC

Contact Person: KIM HONGYONG

Website: https://app.wego-aetherflow.com

Email: Send Email

City: Panama City

Country: Panama

Release id: 50524

View source version on King Newswire:
ValueX (VLX) Announces Dual Listing on Gate.io and MEXC, Expanding Its Global Web3 Carbon Economy Ecosystem

file

Canary Capital Launches the First U.S. Spot Staked INJ ETF (Ticker: INJC)

Brentwood, Tennessee, USA, November 6th, 2026, FinanceWire

Canary Capital Group LLC (“Canary Capital”), a digital asset investment management firm, today announced the launch of the Canary Staked INJ ETF (Ticker: INJC), listed on Nasdaq. The Fund seeks to provide exposure to the price of INJ, the native token of the Injective blockchain network. In addition, the Fund also seeks to earn additional INJ through participation in the Injective network’s proof-of-stake validation process, with net staking rewards reflected in the Fund’s net asset value. 

“The Canary Staked INJ ETF gives investors access to a blockchain purpose-built for finance through a familiar exchange-traded structure, while also enabling investors to benefit from potential staking rewards,” said Steven McClurg, CEO of Canary Capital. “Injective was designed from the ground up for trading, tokenization, markets, and financial applications. We believe investors are increasingly looking past the largest digital assets and toward the specialized networks building the next generation of on-chain financial infrastructure.” 

Injective is a Layer-1 blockchain designed to serve as the technological foundation for on-chain finance. Its purpose-built architecture offers developers pre-built, plug-and-play financial modules, including a fully onchain order book exchange module, enabling rapid development of tokenization, trading, derivatives, and other financial applications. INJ is used to secure the network through staking, to participate in governance, and to pay transaction and trading fees. 

The network also features a unique Community Buyback mechanism that regularly removes INJ from circulation using a portion of revenue generated by applications on the network. Injective has tokenized over $1 Billion in assets to date*, ranking it among the top blockchains for Real-World Assets (RWAs). As of October 22nd, 2026, Injective had processed more than 3.13 billion transactions and permanently burned more than 7.27 million INJ (~$58 million USD) across its monthly token buybacks. In addition, the analytics platform Token Terminal reports approximately 257,300* monthly active addresses on Injective. 

Recent upgrades include Injective Mint, which enables institutions to issue and manage tokenized assets with controls over ownership and transfers. Injective also showcased CypherOS which provides a full stack privacy platform capable of enabling confidential trading, transactions and tokenization. Also, over $25 million* of the native USDC stablecoin has been issued on Injective to support payments and settlement across the network. 

“Investors can now gain exposure to INJ through the brokerage accounts they already use,” said Eric Chen, Co-Founder of Injective Foundation. “We built Injective to bring financial markets onchain. Canary’s launch connects that mission to a broader base of investors, giving them a familiar way to access the asset that powers Injective.” 

For more information on INJC, click here.

Media Contacts 

Canary Capital 

media@canaryetfs.com 

About Canary Capital 

Canary Capital is an investment management firm that blends rigorous risk management, strategic foresight, and innovative thinking to deliver private placement strategies, crypto hedge fund solutions, treasury management solutions, and publicly traded funds, with a focus on enterprise technology. 

About Injective: 

Injective is the first blockchain purpose-built for finance, enabling users, institutions, and AI agents to trade, tokenize, and transact at scale. Proudly made in America, Injective provides foundational blockchain infrastructure for global markets, with embedded financial primitives spanning stablecoins, real-world assets, payments, and programmable perpetuals through a unified onchain engine. Injective is used by Fortune 500 companies, banks, fintechs, and governments to power an open economy where any asset can be accessed anytime, from anywhere. Builders can deploy across multiple virtual machines like EVM (Ethereum Virtual Machine) and WASM (WebAssembly), connect to native financial modules, and launch markets with deep liquidity from day one. INJ is the native token powering the rapidly growing Injective ecosystem and the new internet economy. 

*As of October 2026 

USDC – USDC is a stable digital dollar enabling fast, cheap, global blockchain transactions. 

The Canary Staked INJ ETF (Ticker: INJC) is an exchange-traded product that is not registered under the Investment Company Act of 1940 (the “1940 Act”) and therefore is not subject to the same regulations and protections as ETFs and mutual funds registered under the 1940 Act. Investing involves risk, including the possible loss of principal. An investment in INJC is subject to a high degree of risk and heightened volatility and is not suitable for investors who cannot afford the loss of their entire investment.

The Fund’s investment objectives, risks, charges and expenses should be considered before investing. The prospectus contains this and other important information, and it may be obtained at https://canaryetfs.com/INJC/prospectus/. Read it carefully before investing. 

An investment in INJC is not a direct investment in INJ. Staking rewards are not indicative of the Fund’s performance, are not guaranteed, and may change frequently, including experiencing significant declines. Digital assets, such as INJ, are a relatively new asset class, and the market for digital assets is subject to rapid changes and uncertainty. Digital assets are largely unregulated and digital asset investments may be more susceptible to fraud and manipulation than more regulated investments. 

INJC is subject to rapid price swings, including as a result of actions and statements by influencers and the media, change of assets, and other factors. There is no assurance that INJC will maintain its value over the long-term. 

Staking provides the Trust with the opportunity to create and earn additional INJ. The Trust will be entitled to all INJ generated by the Trust’s staking, after deduction of certain staking-related expenses. This additional INJ will increase the net assets of the Trust, benefiting Shareholders. 

Certain of such INJ may be treated as income to the Trust and may be held for future distribution to Shareholders, subject to procedures and requirements disclosed elsewhere in the Prospectus. 

Staking comes with a risk of loss of INJ. None of the Fund’s assets, including any staked assets, are subject to the protections enjoyed by depositors with Federal Deposit Insurance Corporation (“FDIC”) or Securities Investor Protection Corporation (SIPC) member institutions. The staked assets may also be subject to “slashing” penalties. Slashings occur when a validator attests to two different histories of the chain and penalties occur when a validator is offline for a prolonged period of time. The Fund itself will not engage in staking activities, including the operation of a validator node. Instead, the staking program will be administered by the Fund’s sponsor, who will utilize service providers including the custodians and staking providers. While the Fund’s sponsor does not expect the activities of the staking providers to result in slashing penalties, there can be no guarantee that slashing penalties will not occur. Furthermore, the custodians’ and staking providers’ liability to the Fund for the actions associated with the Staking Program is limited, and the custodians and staking providers may lack the assets or insurance in order to support the recovery of any losses incurred. Accordingly, there can be no guarantee that the Fund would recover any of its staked assets, or the value thereof, if it is subject to slashing or penalties. 

The Fund is new with a limited operating history. 

Paralel Distributors LLC, Marketing Agent. Paralel is unaffiliated with Canary Capital.

Contact

Sarah Cohen
sarah@sjc-pr.com

Cyprus IVF Centre Explains Why Similarly Graded Embryos May Develop Differently

Nicosia, Cyprus, 6th Nov 2026 – Cyprus IVF Centre has shared patient information explaining why two embryos that receive the same grade do not necessarily have the same potential.

Embryo grading is based on visible characteristics, including cell development and morphology. It provides valuable information about embryo quality during IVF treatment.

Embryo grading assesses an embryo’s appearance and development; it does not determine its chromosomal status. Genetic testing, where clinically indicated, evaluates a different aspect of the embryo and likewise cannot guarantee implantation or treatment success.

However, grading cannot fully predict an embryo’s developmental potential or implantation outcome. Even embryos with the same grade may behave differently, as factors beyond their appearance can influence development.

At Cyprus IVF Centre, the embryology team considers embryo grading alongside other relevant developmental and clinical information when assessing embryos for treatment.

Embryo grading supports the assessment of embryos. It does not guarantee implantation or treatment success.

“Two embryos can receive the same grade and still develop differently. Grading gives our embryology team valuable information, which we consider alongside other developmental and clinical information when assessing embryos. Embryo grading is an important part of the picture, but never the whole picture.”

— Ümit İnak, Director, Cyprus IVF Centre

Patients considering treatment are welcome to ask the team how their embryos will be assessed and what grading means for their own treatment. More information is available at:

embryo grading in IVF

Medically reviewed by the Cyprus IVF Centre Medical and Embryology Team, 5 November 2026

About Cyprus IVF Centre

Cyprus IVF Centre, home of Team Miracle, is an IVF and fertility clinic in Cyprus providing assisted reproductive treatment for UK and international patients. Fertility care is supported by clinical and embryology teams, with laboratory processes forming an integral part of its treatment services.

Media Contact

Organization: Team Miracle – Cyprus IVF Centre

Contact Person: Team Miracle – Cyprus IVF Centre

Website: https://cyprusivfcentre.com/

Email: Send Email

City: Nicosia

Country: Cyprus

Release id: 50535

View source version on King Newswire:
Cyprus IVF Centre Explains Why Similarly Graded Embryos May Develop Differently

file

FX Junction Publishes Marketplace Review Showing Copy Traders Favor Longer Verified Track Records Over Higher Returns

Fomboni, Comoros, November 6th, 2026, FinanceWire

FX Junction has published findings from a review of copy-trading activity on its marketplace, revealing that investors tend to follow traders with longer verified trading histories rather than those with the highest returns. The review highlights the importance of established trading records in investor decisions and provides insight into copy-trading behavior across the platform.

In copy trading, also called social trading, an investor links their own brokerage account to the account of another trader, known as a signal provider. From that point, every position the chosen trader opens is mirrored automatically in the investor’s account, scaled to the amount the investor has allocated. The investor’s money never leaves their own broker; what is shared is the trading decision, not the capital.

Across the platform’s verified signal providers, the distribution of copying activity is the point. Fewer than six in ten of them have attracted copiers; the rest have none.

Among those who are copied, the allocation runs against the return table. The five best-performing accounts on the platform, with total returns between 197 and 273 percent, together account for less than half a percent of all copying links. Their verified track records run from under seven months to just over fifteen. Accounts ranked below them returning 192 and 182 percent hold more than a quarter of all copying links on the platform and their verified histories are more than three times longer than the longest record among the top five.

Measured Across The Whole Marketplace, The Pattern Holds:

Length of record: providers with at least one copier have a median verified history of 21.6 months. Providers with no copiers have a median of 8.8 months.

Returns: the median total return is 25.2 percent for copied providers and 26.8 percent for providers with no copiers – effectively the same.

Own capital at stake: the median account equity of a copied provider is 25,237 US dollars, against 3,741 US dollars for providers with no copiers.

The platform’s wider counters stood at 41,008 registered members, 26,261,890 trades executed and 12,681 linked trading accounts as of 4 November 2026. Member funds always remain with the trader’s own broker. FX Junction does not hold client capital.

About FX Junction

The investment and trading platform FX Junction is one of the world’s leading social trading networks. In the area of CFDs and forex, FX Junction had already established itself as one of the global leaders among social platforms for traders.

FX Junction was founded in 2011. The company’s launch was backed by a Swiss investor through Pine Group SA, and its U.S. expansion led by Ryan Novak.

For more information about the company, visit: https://www.fxjunction.com

Risk Warning

FX Junction does not provide investment advice and individual traders should make their own decisions or seek independent advice. The value of investment can go down as well as up and may receive back less than the original investment. 

Trading in Leverage products carries a high level of risk and may not be suitable for all investors. Past performance of an investment is no guide to its performance in the future. Investments, or income from them, can go down as well as up. May not necessarily get back the amount that invested. All opinions, news, analysis, prices or other information contained in the communication and on the website, are provided as general market commentary and do not constitute investment advice, nor a solicitation or recommendation to buy or sell any financial instruments or other financial products or services.

Contact

Team of analysts
FX Junction
Marketing@fxjunction.com

ValueX (VLX) Announces Dual Listing on Gate.io and MEXC, Expanding Its Global Web3 Carbon Economy Ecosystem

ValueX (VLX) is scheduled to list on two major global cryptocurrency exchanges on November 7, 2026, at 08:00 UTC.

Panama City, Panama, 6th Nov 2026 — VLX Aetherflow Technologies INC has announced the planned simultaneous listing of its digital asset, ValueX (VLX), on global cryptocurrency exchanges Gate.io and MEXC.

The upcoming listings mark a key milestone in ValueX’s global expansion strategy and its mission to connect blockchain technology with real-world environmental industries.

Advancing the Web3 Carbon Economy

ValueX is developing a blockchain-based carbon economy ecosystem utilizing Avalanche-based, EVM-compatible technology. The project aims to enhance transparency, traceability, and reliability in carbon-related data through blockchain-integrated Measurement, Reporting, and Verification (MRV) systems. Its primary application areas include maritime transportation, forestry, and renewable energy.

Building a Global Blockchain Ecosystem

Through its ValueX Chain infrastructure, the project seeks to integrate environmental data, IoT technologies, and decentralized finance (DeFi) into a scalable Web3 ecosystem. The planned Gate.io and MEXC listings are expected to increase global accessibility and support broader participation from blockchain developers, environmental businesses, and digital asset communities.

ValueX aims to accelerate the digital transformation of the carbon economy by connecting environmental sustainability with blockchain innovation.

Listing Information

  • Token: ValueX (VLX)
  • Exchanges: Gate.io & MEXC
  • Listing Date: November 7, 2026
  • Listing Time: 08:00 UTC
  • Issuer: VLX Aetherflow Technologies INC

Listing details are subject to official exchange confirmation. This announcement does not constitute investment advice.

Media Contact

Organization: VLX Aetherflow Technologies INC

Contact Person: KIM HONGYONG

Website: https://app.wego-aetherflow.com

Email: Send Email

City: Panama City

Country: Panama

Release id: 50524

View source version on King Newswire:
ValueX (VLX) Announces Dual Listing on Gate.io and MEXC, Expanding Its Global Web3 Carbon Economy Ecosystem

file

Muddlefox Introduces Free Instagram Font Generator for Creating Stylish, Copy-and-Paste Text Without Registration

United States, 6th Nov 2026 — Muddlefox has introduced its free Instagram Font Generator, a browser-based online tool designed to help social media users transform ordinary text into stylish, decorative fonts for Instagram bios, captions, comments, display names, and Stories. The tool provides a simple way to personalize Instagram content without requiring users to create an account, install software, or pay subscription fees.

As social media continues to play an important role in personal branding, communication, and digital marketing, users increasingly look for ways to make their profiles and posts more visually distinctive. Muddlefox’s Instagram Font Generator addresses this demand by offering a collection of text styles that users can generate, preview, and copy directly into their preferred Instagram sections.

The tool supports a variety of text styles, including bold serif, italic script, double-struck, monospace, circled, squared, small caps, and bubble lettering. It also includes aesthetic and soft-style variations for users who want a more creative appearance. These options allow individuals, content creators, influencers, and businesses to experiment with different visual presentations while maintaining the original meaning of their messages.

One of the main features of the platform is its live preview functionality. As users enter text into the generator, available font styles appear automatically, making it easier to compare different designs before choosing one. Each style includes an individual copy button, allowing users to select their preferred version and paste it into an Instagram bio, caption, comment, or other compatible text field.

The platform is particularly useful for people who want to improve the appearance of their Instagram profiles without spending time searching for decorative Unicode characters or manually formatting individual letters. By bringing multiple styles together in one accessible interface, Muddlefox aims to simplify the process of creating fancy text for everyday social media use.

The Instagram Font Generator also includes an optional bio mode designed specifically for Instagram profile descriptions. This feature provides a character count that helps users monitor their text against Instagram’s 150-character bio limit. Since certain decorative Unicode characters may count as more than one character, the counter offers additional guidance when users are preparing a styled profile description.

Privacy and accessibility are central aspects of the tool’s design. The generator runs directly in the user’s web browser, meaning text entered into the tool is not sent to a Muddlefox server for conversion. Users can type their content, select a preferred style, and copy the resulting text without creating an account or submitting personal information.

The service is completely free, with no login requirements or usage limits. This makes it accessible to occasional Instagram users as well as individuals who regularly create social media content and need a convenient way to generate different text styles.

Users searching for an Instagram font generator, Instagram fonts copy and paste, cool fonts for Instagram, or a simple fancy text generator can access the tool directly through the Muddlefox website. The platform is designed to make creative text formatting straightforward, whether someone is updating a personal bio, preparing a caption, or adding decorative lettering to a social media comment.

The Instagram Font Generator is part of Muddlefox’s broader collection of free online tools. Through its free tools hub, the company provides accessible browser-based utilities intended to make everyday digital tasks easier and more convenient.

With its combination of multiple font styles, instant previews, individual copy buttons, optional bio character counting, and browser-based processing, Muddlefox aims to provide a practical solution for users who want more flexibility when presenting text on Instagram.

To explore the free Instagram Font Generator, visit:

https://muddlefox.com/instagram-font-generator/

For more information about Muddlefox and its collection of free online tools, visit:

https://muddlefox.com/

About Muddlefox

Muddlefox provides a collection of free online tools designed to simplify everyday digital tasks. Its browser-based utilities focus on accessibility and ease of use, helping users complete common activities without unnecessary registration requirements or complicated software installations. The company’s Instagram Font Generator enables users to transform standard text into decorative, copy-and-paste styles for social media profiles and content.

Media Contact:

Team Muddlefox
Muddlefox
Email: support@muddlefox.com
Website: https://muddlefox.com/
Instagram Font Generator: https://muddlefox.com/instagram-font-generator/

Media Contact

Organization: Muddlefox

Contact Person: Team Muddle Fox

Website: https://muddlefox.com/instagram-font-generator/

Email: Send Email

Country: United States

Release id: 50532

View source version on King Newswire:
Muddlefox Introduces Free Instagram Font Generator for Creating Stylish, Copy-and-Paste Text Without Registration

file

Born in the Exam Room, a Korean Skincare Brand Meets the World in Hong Kong

DERCENT, the dermocosmetic line created by a dermatologist with 21 years of clinical experience, brings clinical data and skin-barrier science to Cosmoprof Asia Hong Kong 2026.

Seoul, South Korea, 6th Nov 2026 — Stand in front of any skincare shelf, and the same questions surface every time. Which ingredient is having its moment this season? Which product will transform my skin the fastest, and the most visibly? Lately, though, the global beauty market has been pointing somewhere else. A growing number of consumers are looking past quick cosmetic payoffs and asking about something more fundamental first: the skin barrier, hydration, soothing—the health of the skin itself. That shift helps explain why dermocosmetics have outgrown their status as a single category and are fast becoming the benchmark for the entire market.

Against this backdrop, one Korean brand merits a closer look. DERCENT is led by CEO Dr. Hong-seok Kim, a board-certified dermatologist with 21 years of clinical practice behind him. From November 11 to 13, the brand will take the stage at Cosmoprof Asia Hong Kong 2026.

What “Dermatologist-Made” Really Means

“Doctor-developed” is hardly a novel label in skincare anymore. What it actually means, however, varies widely from brand to brand. For DERCENT, the starting point is the exam room. The brand’s product philosophy rests on the clinical experience gained from treating tens of thousands of patients firsthand—and on the perspective of a physician who has spent years confronting a wide spectrum of skin concerns.

That perspective begins one step before the goal of making skin look beautiful. First comes an understanding of the skin’s structure and condition; only then come the questions of which ingredients the skin needs right now and what role each product should play. The logic is simple: rather than piling flashy actives onto a compromised barrier, restore the fundamentals first—barrier function, hydration, and calm. That a dermatologist leads the brand personally is precisely what sets DERCENT apart.

One Routine, Six Distinct Roles

DERCENT’s lineup comprises six products. Notably, none of them is pitched as a do-it-all miracle. Instead, each is assigned a clear role, targeting one specific skin concern. Two pillars anchor the line: hydration care centered on aquaporins—often described as the skin’s water channels—and conditioning care built on panthenol, ceramides, and cica.

The routine opens with cleansing. Pro Derma Low pH Gel Cleanser, a mildly acidic formula with a pH of 4.5 to 5.5, lifts away impurities and excess oil while keeping irritation to a minimum. Humectants such as glyceryl glucoside and glycerin help ease the post-cleanse tightness so many people know all too well. The thinking here is less about cleansing harder and more about cleansing with less harm.

Tone and texture come next. As its name suggests, Pro Derma N5T2 Aquaporin Toner is built around 5% niacinamide and 2% tranexamic acid (TXA). Alpha-arbutin and a vitamin C derivative help even out skin tone, while AHAs and PHAs gently clear away dead skin cells. The result is a toner that tackles dullness, discoloration, and uneven texture at once—without losing sight of hydration.

Hydration is the heart of the routine. Pro Derma Hydrating Aquaporin B5 Serum pairs glyceryl glucoside, which supports aquaporin activity, with 5% panthenol and seven types of hyaluronic acid. It is formulated to break a familiar vicious cycle: dehydration beneath the surface weakens the barrier, and a weakened barrier leaves skin more prone to sensitivity. Its lightweight texture makes it as well suited to dehydrated oily skin as it is to dry skin.

The final steps focus on reinforcing the barrier and sealing in moisture. Barrier Cica Cream combines the 4-CICA Soothing Complex—four cica compounds, including asiaticoside and madecassoside—with panthenol, ceramides, cholesterol, fatty acids, and natural moisturizing factors (NMF). The silicone-free formula is also designed to support recovery when skin turns sensitive after in-office procedures, a consideration that speaks to the brand’s dermatological roots.

Squalane Barrier Oil is a concentrated oil containing 92.8% sugarcane-derived squalane. Because squalane closely mimics the skin’s own sebum, it forms a protective film that locks in moisture without the heaviness typical of facial oils, making it light enough even for oily skin. The amount can be adjusted to suit how dry the skin feels.

And for special occasions, there is a mask. Jelly Mask for Dry and Sensitive Skin uses a gel-coated sheet that clings closely to the face, delivering a rush of cooling hydration to skin that feels flushed or reactive. Formulated with three types of hyaluronic acid, beta-glucan, ceramide NP, and niacinamide, it works as a rescue treatment for those days when makeup refuses to sit smoothly.

Beyond the Ingredient List: The Numbers

Any brand that claims the dermocosmetic mantle must eventually answer one question: Does it actually change the skin? DERCENT answers with data from human clinical testing. After four weeks of use, all three of its key products improved skin hydration, skin density, and deep skin hydration while reducing transepidermal water loss (TEWL).

Pro Derma Hydrating Aquaporin B5 Serum improved skin hydration by 34.55%, skin density by 21.59%, and deep skin hydration by 9.88%, and reduced TEWL by 18.51%. Barrier Cica Cream improved skin hydration by 23.81%, skin density by 7.72%, and deep skin hydration by 27.46%, and reduced TEWL by 24.90%. Squalane Barrier Oil improved skin hydration by 15.54%, skin density by 13.94%, and deep skin hydration by 13.52%, and reduced TEWL by 19.03%.

What stands out is that each product shows its own distinct strengths. The serum excels in surface hydration and skin density, while the cream shines in deep hydration and in guarding against moisture loss. The numbers bear out the brand’s claim that every product was designed for a specific role, and they explain why DERCENT plans to lead with data—not just texture and ingredients—when it sits down with international buyers.

From Goyang to Hong Kong—and Beyond

The move to Hong Kong is no sudden leap. From October 15 to 17, DERCENT showcased its lineup at K-Beauty Expo Korea 2026 at KINTEX in Goyang, just outside Seoul, where it held B2B meetings with overseas companies, including a Shanghai-based e-commerce firm. The buyer connections forged at home laid the groundwork for this next step.

Cosmoprof Asia, held at the Hong Kong Convention and Exhibition Centre (HKCEC) in Wan Chai, is one of Asia’s premier international B2B beauty trade shows, drawing brands, distributors, retailers, and buyers from around the world. At Booth 1E-R1A, DERCENT will feature large-screen brand content alongside a hands-on product experience zone. Through prearranged meetings, the brand also plans to sit down with distributors, retailers, and e-commerce companies from across Asia and beyond to explore market entry, country by country.

In the End, It Comes Back to the Skin

In a market where countless brands race to tout newer ingredients and stronger results, DERCENT’s message is refreshingly simple: help the skin restore its own health and balance. Dr. Kim puts the philosophy this way:

“Over the years, I have treated patients with a wide range of skin concerns, and throughout that time, I have kept asking what the skin truly needs to stay healthy. DERCENT grew out of that long clinical experience and a professional understanding of the skin. Our guiding principle is to look beyond trendy ingredients and short-lived gratification and to create products that support the skin’s natural health and balance.”

Now, the expertise built over 21 years in the exam room is ready to cross borders. With communication tailored to each market and its consumers, and an identity firmly grounded in skin science, DERCENT is about to open its next chapter in Hong Kong. How that chapter answers the question of what makes skincare truly good will be well worth watching.

Media Contact

Organization: PRNam Cosmetic Co., Ltd.

Contact Person: Rachel Kim

Website: https://dercent.co.kr

Email: Send Email

City: Seoul

Country: South Korea

Release id: 50527

View source version on King Newswire:
Born in the Exam Room, a Korean Skincare Brand Meets the World in Hong Kong

file

ALLCOM Smart Tumbler to Launch on Kickstarter, Bringing Temperature Control to Everyday Drinks

A CES 2026 Innovation Awards Honoree, ALLCOM combines Peltier-based heating and cooling with app-connected temperature control in a portable tumbler.

United States, 6th Nov 2026 – ALLCOM is preparing to bring the ALLCOM Smart Tumbler to Kickstarter. Designed for people who want more control over the temperature of their drinks, ALLCOM uses Peltier semiconductor technology to actively heat or cool beverages and help maintain a preferred temperature within a range of 50–176°F (10–80°C).

Unlike a conventional tumbler that primarily helps retain a drink’s existing temperature, ALLCOM is designed to adjust it. Users can set their preferred temperature through the ALLCOM app, with an internal sensor and Bluetooth connection supporting real-time temperature control.

The tumbler is designed for a range of everyday moments, from enjoying coffee at your desk to keeping a cold drink cool while watching a game. Its detachable stainless-steel cup can be separated from the temperature-control base for cleaning, while the portable design makes it easy to bring along.

ALLCOM’s approach to temperature-controlled drinkware has been recognized as a 2026 CES Innovation Awards Honoree in Home Appliances by the Consumer Technology Association (CTA). The CES listing highlights the tumbler’s Peltier-based heating and cooling, app connectivity, and detachable stainless-steel vessel.

The ALLCOM Smart Tumbler is coming soon to Kickstarter. Visit the PRE-LAUNCH PAGE to follow the campaign and receive updates.

About ALLCOM

ALLCOM develops temperature-control products designed to make everyday routines more convenient. With the ALLCOM Smart Tumbler, the company brings active heating and cooling technology into reusable drinkware, helping people enjoy their beverages at a temperature they choose.

Media Contact

Organization: ALLCOM

Contact Person: Media Relations

Website: https://all-comfort.com/

Email: Send Email

Country: United States

Release id: 50526

View source version on King Newswire:
ALLCOM Smart Tumbler to Launch on Kickstarter, Bringing Temperature Control to Everyday Drinks

file